≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Carcinoma in situ of skin (controls excluding all cancers)

Endpoint Browser PheWeb

CD2_INSITU_SKIN_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector
diagram bullet

Check conditions

not C3_SKIN

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D04
Cause of death: ICD-10 D04
Cancer registry: Topography ICD-O-3 C44
Cancer registry: Morphology ICD-O-3 ANY
Cancer registry: Behaviour codes 2

3 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

2135

diagram downward connector
CD2_INSITU_SKIN_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF9
Parent code in ICD-10 D00-D09
Name in latin Carcinoma in situ cervicis uteri

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 2135 1085 1050
Unadjusted prevalence (%) 0.52 0.47 0.58
Mean age at first event (years) 72.56 72.08 73.05

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.07 3.70 [2.50, 5.47] 6.8e-11 277
15 years 0.01 1.53 [1.05, 2.25] 2.8e-2 109
5 years 0.00 3.24 [2.31, 4.54] 8.1e-12 119
1 year 0.00 5.19 [3.41, 7.90] 1.6e-14 41

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_INSITU_SKIN_EXALLC – Carcinoma in situ of skin (controls excluding all cancers)
GWS hits: 4

Survival analyses between endpoints

↥

Plot

before Carcinoma in situ of skin (controls excluding all cancers)
after Carcinoma in situ of skin (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Carcinoma in situ of skin (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.